Target
Complement factor D
Ligand
BDBM340226
Substrate
n/a
Meas. Tech.
Inhibition Assay
IC50
>10000±n/a nM
Citation
 Wiles, JAPhadke, ASWang, XChen, DHashimoto, AGadhachanda, VRPais, GWang, QAgarwal, ADeshpande, M Compounds for treatment of complement mediated disorders US Patent  US9758537 Publication Date 9/12/2017 
Target
Name:
Complement factor D
Synonyms:
Adipsin | C3 convertase activator | CFAD_HUMAN | CFD | DF | PFD | Properdin factor D
Type:
Protein
Mol. Mass.:
27039.19
Organism:
Homo sapiens (Human)
Description:
P00746
Residue:
253
Sequence:
MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA
  
Inhibitor
Name:
BDBM340226
Synonyms:
(2S,4R)-1-(2-(3-acetyl- 1H-indol-1-yl)acetyl)- N-(3-chloro-2- fluorobenzyl)-4-(7- methoxy-2- phenylquinolin-4- yloxy)pyrrolidine-2- carboxamide | US9758537, Compound 29
Type:
Small organic molecule
Emp. Form.:
C40H34ClFN4O5
Mol. Mass.:
705.173
SMILES:
COc1ccc2c(O[C@@H]3C[C@H](N(C3)C(=O)Cn3cc(C(C)=O)c4ccccc34)C(=O)NCc3cccc(Cl)c3F)cc(nc2c1)-c1ccccc1 |r|
Structure:
Search PDB for entries with ligand similarity: